Patents by Inventor Charles R. Yates

Charles R. Yates has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-inflammatory quinic acid derivatives for oral administration
    Patent number: 8115031
    Abstract: Disclosed are compounds comprising analogs of quinic acids or shikimic acids having anti-inflammatory properties. The compounds are suitable for oral administration, stable, and demonstrate significant efficacy in inhibiting NF-kB, inhibiting leukocyte adhesion, and inhibiting other factors and cytokines known to be involved in inflammatory disease.
    Type: Grant
    Filed: November 10, 2008
    Date of Patent: February 14, 2012
    Inventors: Charles R. Yates, Duane D. Miller, Kui Zeng, Karin Emmons Thompson
  • Tri-aryl/heteroaromatic cannabinoids and use thereof
    Patent number: 7888365
    Abstract: Cannabinoid derivatives according to formula (I) are disclosed wherein, X, Y, R1, R2, and W can have the definitions provided herein. Without limitation, use of such compounds, their salts or pro-drug, or compositions containing the compounds, salts, or pro-drug, to modify the activity of CB1 and CB2 receptors and treat conditions mediated by these receptors.
    Type: Grant
    Filed: March 3, 2008
    Date of Patent: February 15, 2011
    Assignee: The University of Tennessee Research Foundation
    Inventors: Bob M. Moore, II, Himanshu Bhattacharjee, Charles R. Yates, Leslie Stuart
  • Anti-Inflammatory Quinic Acid Derivatives for Oral Administration
    Publication number: 20090234015
    Abstract: Disclosed are compounds comprising analogs of quinic acids or shikimic acids having anti-inflammatory properties. The compounds are suitable for oral administration, stable, and demonstrate significant efficacy in inhibiting NF-kB, inhibiting leukocyte adhesion, and inhibiting other factors and cytokines known to be involved in inflammatory disease.
    Type: Application
    Filed: November 10, 2008
    Publication date: September 17, 2009
    Inventors: Charles R. Yates, Duane D. Miller, Kui Zeng, Karin Emmons Thompson
  • Tri-aryl/heteroaromatic cannabinoids and use thereof
    Publication number: 20080234293
    Abstract: Cannabinoid derivatives according to formula (I) are disclosed wherein, X, Y, R1, R2, and W can have the definitions provided herein. Without limitation, use of such compounds, their salts or pro-drug, or compositions containing the compounds, salts, or pro-drug, to modify the activity of CB1 and CB2 receptors and treat conditions mediated by these receptors.
    Type: Application
    Filed: March 3, 2008
    Publication date: September 25, 2008
    Inventors: Bob M. Moore, Himanshu Bhattacharjee, Charles R. Yates, Leslie Stuart
  • Real-time polymerase chain reaction-based genotyping assay for single nucleotide polymorphism
    Patent number: 7018816
    Abstract: The present invention provides fluorescence-based real-time PCR assays for the rapid detection of single nucleotide polymorphisms (SNPs). The genotyping assay can be used to detect SNPs of a number of genes of interest that include, but are not limited to, the human multidrug resistance gene (MDR1) single nucleotide polymorphisms C3435T and G2677T, and cytochrome P-450 3A5 single nucleotide polymorphisms CYP3A5*3 (A22893G) and CYP3A5*6 (G30597A).
    Type: Grant
    Filed: March 25, 2004
    Date of Patent: March 28, 2006
    Assignee: The University of Tennessee Research Foundation
    Inventors: Charles R. Yates, Duane Miller, Dick Gourley, Pengfei Song
  • Real-time polymerase chain reaction-based genotyping assay for single nucleotide polymorphism
    Publication number: 20040191822
    Abstract: The present invention provides fluorescence-based real-time PCR assays for the rapid detection of single nucleotide polymorphisms (SNPs). The genotyping assay can be used to detect SNPs of a number of genes of interest that include, but are not limited to, the human multidrug resistance gene (MDR1) single nucleotide polymorphisms C3435T and G2677T, and cytochrome P-450 3A5 single nucleotide polymorphisms CYP3A5*3 (A22893G) and CYP3A5*6 (G30597A).
    Type: Application
    Filed: March 25, 2004
    Publication date: September 30, 2004
    Inventors: Charles R. Yates, Duane Miller, Dick Gourley, Pengfei Song